Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $337.08, but opened at $325.85. Bio-Rad Laboratories shares last traded at $325.85, with a volume of 198 shares traded.
Bio-Rad Laboratories Stock Performance
The firm has a market cap of $9.12 billion, a P/E ratio of -11.92 and a beta of 0.72. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The company’s 50-day moving average is $336.21 and its two-hundred day moving average is $318.03.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Further Reading
- Five stocks we like better than Bio-Rad Laboratories
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Financial Services Stocks Investing
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Where to Find Earnings Call Transcripts
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
